$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Exploring the Link Between Exogenous Thyroid Hormones and Dementia Symptoms: A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System

The Annals of pharmacotherapy, v.59 no.1, 2025년, pp.23 - 33  

Zhou, Jianxing (School of Pharmacy, Fujian Medical University, Fuzhou, China) ,  Lai, Weipeng (School of Pharmacy, Fujian Medical University, Fuzhou, China) ,  Wei, Zipeng (School of Pharmacy, Fujian Medical University, Fuzhou, China) ,  Xu, Baohua (School of Pharmacy, Fujian Medical University, Fuzhou, China) ,  Liu, Maobai (School of Pharmacy, Fujian Medical University, Fuzhou, China) ,  Zhang, Nanwen (School of Pharmacy, Fujian Medical University, Fuzhou, China) ,  Wu, Xuemei (School of Pharmacy, Fujian Medical University, Fuzhou, China)

Abstract AI-Helper 아이콘AI-Helper

Background: A growing body of evidence indicates a strong association between exogenous thyroid hormone (ETH) and brain health. Establishing the potential relationship between ETH therapy and dementia symptoms is crucial for patients with thyroid disorders. Objective: In this study, we investigate t...

참고문헌 (46)

  1. Epstein, Franklin H., Klein, Irwin, Ojamaa, Kaie. Thyroid Hormone and the Cardiovascular System. The New England journal of medicine, vol.344, no.7, 501-509.

  2. van Heemst, Diana. The ageing thyroid: implications for longevity and patient care. Nature reviews. Endocrinology, vol.20, no.1, 5-15.

  3. Taylor, Peter N., Albrecht, Diana, Scholz, Anna, Gutierrez-Buey, Gala, Lazarus, John H., Dayan, Colin M., Okosieme, Onyebuchi E.. Global epidemiology of hyperthyroidism and hypothyroidism. Nature reviews. Endocrinology, vol.14, no.5, 301-316.

  4. Pizzato, Margherita, Li, Mengmeng, Vignat, Jerome, Laversanne, Mathieu, Singh, Deependra, La Vecchia, Carlo, Vaccarella, Salvatore. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. The lancet. Diabetes & endocrinology, vol.10, no.4, 264-272.

  5. Bould, H., Panicker, V., Kessler, D., Durant, C., Lewis, G., Dayan, C., Evans, J.. Investigation of thyroid dysfunction is more likely in patients with high psychological morbidity. Family practice, vol.29, no.2, 163-167.

  6. Taylor, Peter N, Iqbal, Ahmed, Minassian, Caroline, Sayers, Adrian, Draman, Mohd S, Greenwood, Rosemary, Hamilton, William, Okosieme, Onyebuchi, Panicker, Vijay, Thomas, Sara L, Dayan, Colin. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.. JAMA internal medicine, vol.174, no.1, 32-39.

  7. Metwalley, Kotb Abbass, Farghaly, Hekma Saad. Subclinical hyperthyroidism in children. Journal of pediatric endocrinology & metabolism : JPEM, vol.36, no.4, 342-345.

  8. Tan, Stephanie Y., Chubb, S. A. Paul, Flicker, Leon, Almeida, Osvaldo P., Golledge, Jonathan, Hankey, Graeme J., Yeap, Bu B.. Changes in thyroid function and evolution of subclinical thyroid disease in older men. Clinical endocrinology, vol.100, no.2, 170-180.

  9. Drugs for Hypothyroidism. The Medical letter on drugs and therapeutics, vol.65, no.1670, 25-29.

  10. Kantor, E. D.. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. JAMA : the journal of the American Medical Association, vol.314, no.17, 1818-1818.

  11. Adams, Roy, Oh, Esther S., Yasar, Sevil, Lyketsos, Constantine G., Mammen, Jennifer S.. Endogenous and Exogenous Thyrotoxicosis and Risk of Incident Cognitive Disorders in Older Adults. JAMA internal medicine, vol.183, no.12, 1324-.

  12. Salehipour, A., Dolatshahi, M., Haghshomar, M., Amin Dr., Jay. The Role of Thyroid Dysfunction in Alzheimer's Disease: A Systematic Review and Meta-Analysis. The journal of prevention of alzheimer's disease, vol.10, no.2, 276-286.

  13. Folkestad, Lars, Brandt, Frans, Lillevang-Johansen, Mads, Brix, Thomas Heiberg, Hegedüs, Laszlo. Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts. Thyroid : official journal of the American Thyroid Association, vol.30, no.5, 672-680.

  14. Yeap, Bu B., Alfonso, Helman, Chubb, S. A. Paul, Puri, Gaurav, Hankey, Graeme J., Flicker, Leon, Almeida, Osvaldo P.. Higher Free Thyroxine Levels Predict Increased Incidence of Dementia in Older Men: The Health In Men Study. The Journal of clinical endocrinology & metabolism, vol.97, no.12, E2230-E2237.

  15. Aubert, Carole E., Bauer, Douglas C., da Costa, Bruno R., Feller, Martin, Rieben, Carole, Simonsick, Eleanor M., Yaffe, Kristine, Rodondi, Nicolas. The association between subclinical thyroid dysfunction and dementia: The Health, Aging and Body Composition (Health ABC) Study. Clinical endocrinology, vol.87, no.5, 617-626.

  16. Chaker, Layal, Wolters, Frank J., Bos, Daniel, Korevaar, Tim I.M., Hofman, Albert, van der Lugt, Aad, Koudstaal, Peter J., Franco, Oscar H., Dehghan, Abbas, Vernooij, Meike W., Peeters, Robin P., Ikram, M. Arfan. Thyroid function and the risk of dementia : The Rotterdam Study. Neurology, vol.87, no.16, 1688-1695.

  17. Zhou, Jianxing, Wei, Zipeng, Chen, Shengyang, Xie, Helin, Huang, Wei, Liu, Maobai, Wu, Xuemei. Movement disorders associated with antiseizure medications: A real‐world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System. British journal of clinical pharmacology, vol.89, no.11, 3389-3400.

  18. Zhou, Jianxing, Wei, Zipeng, Xu, Baohua, Liu, Maobai, Xu, Ruichao, Wu, Xuemei. Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database. Frontiers in pharmacology, vol.13, 1039867-.

  19. Ren, Weidong, Wang, Weihua, Guo, Yanli. Analysis of Adverse Reactions of Aspirin in Prophylaxis Medication Based on FAERS Database. Computational and mathematical methods in medicine : CMMM, vol.2022, 7882277-.

  20. Yu, Roger J., Krantz, Matthew S., Phillips, Elizabeth J., Stone Jr., Cosby A.. Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS). The journal of allergy and clinical immunology. in practice, vol.9, no.2, 819-829.e2.

  21. Hu, Yang, Bai, Ziyu, Tang, Yan, Liu, Rongji, Zhao, Bin, Gong, Jian, Mei, Dan. Fournier Gangrene Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Pharmacovigilance Study with Data from the U.S. FDA Adverse Event Reporting System. Journal of diabetes research, vol.2020, 3695101-.

  22. Liu, Lulu, Chen, Jia, Wang, Lei, Chen, Chen, Chen, Li. Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database. Frontiers in endocrinology, vol.13, 1043789-.

  23. Tada, Keisuke, Maruo, Kazushi, Isogawa, Naoki, Yamaguchi, Yusuke, Gosho, Masahiko. Borrowing external information to improve Bayesian confidence propagation neural network. European journal of clinical pharmacology, vol.76, no.9, 1311-1319.

  24. Rothman, Kenneth J., Lanes, Stephan, Sacks, Susan T.. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiology and drug safety, vol.13, no.8, 519-523.

  25. Zhai, Yinghong, Ye, Xiaofei, Hu, Fangyuan, Xu, Jinfang, Guo, Xiaojing, Zhuang, Yonglong, He, Jia. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system. Journal for immunotherapy of cancer, vol.7, no.1, 286-.

  26. Norén, G Niklas, Hopstadius, Johan, Bate, Andrew. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Statistical methods in medical research, vol.22, no.1, 57-69.

  27. van Puijenbroek, Eugéne P., Bate, Andrew, Leufkens, Hubert G. M., Lindquist, Marie, Orre, Roland, Egberts, Antoine C. G.. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiology and drug safety, vol.11, no.1, 3-10.

  28. Xia, Shuang, Gong, Hui, Zhao, Yichang, Guo, Lin, Wang, Yikun, Ma, Rui, Zhang, Bikui, Sarangdhar, Mayur, Noguchi, Yoshihiro, Yan, Miao. Tumor Lysis Syndrome Associated with Monoclonal Antibodies in Patients with Multiple Myeloma: A Pharmacovigilance Study Based on the FAERS Database. Clinical pharmacology and therapeutics, vol.114, no.1, 211-219.

  29. Sauzet, Odile, Carvajal, Alfonso, Escudero, Antonio, Molokhia, Mariam, Cornelius, Victoria R.. Illustration of the Weibull Shape Parameter Signal Detection Tool Using Electronic Healthcare Record Data. Drug safety : an international journal of medical toxicology and drug experience, vol.36, no.10, 995-1006.

  30. Anderson, Nora, Borlak, Juergen. Correlation versus Causation? Pharmacovigilance of the Analgesic Flupirtine Exemplifies the Need for Refined Spontaneous ADR Reporting. PloS one, vol.6, no.10, e25221-.

  31. Fusaroli, Michele, Raschi, Emanuel, Giunchi, Valentina, Menchetti, Marco, Rimondini Giorgini, Roberto, De Ponti, Fabrizio, Poluzzi, Elisabetta. Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System. The international journal of neuropsychopharmacology, vol.25, no.9, 727-736.

  32. Raschi, Emanuel, Fusaroli, Michele, Ardizzoni, Andrea, Poluzzi, Elisabetta, De Ponti, Fabrizio. Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment. Breast cancer research and treatment, vol.186, no.1, 219-227.

  33. von Elm, Erik, Altman, Douglas G, Egger, Matthias, Pocock, Stuart J, Gøtzsche, Peter C, Vandenbroucke, Jan P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PLoS medicine, vol.4, no.10, e296-.

  34. Rabbito, Alessandro, Dulewicz, Maciej, Kulczyńska-Przybik, Agnieszka, Mroczko, Barbara. Biochemical Markers in Alzheimer’s Disease. International journal of molecular sciences, vol.21, no.6, 1989-.

  35. Scheltens, Philip, De Strooper, Bart, Kivipelto, Miia, Holstege, Henne, Chételat, Gael, Teunissen, Charlotte E, Cummings, Jeffrey, van der Flier, Wiesje M. Alzheimer's disease. The Lancet, vol.397, no.10284, 1577-1590.

  36. Sawicka-Gutaj, Nadia, Zawalna, Natalia, Gut, Paweł, Ruchała, Marek. Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions. Pharmacological reports : Pr, vol.74, no.5, 847-858.

  37. De Leo, S., Lee, S.Y., Braverman, L.E.. Hyperthyroidism. The Lancet, vol.388, no.10047, 906-918.

  38. Yu, Juebo. Trends in the incidence of thyroid cancer among US persons from 2000 to 2019. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), vol.33, no.1, 5-10.

  39. Mirahmad, Maryam, Mansour, Asieh, Moodi, Mitra, Safkhani, Elaheh, Haghpanah, Vahid, Asili, Pooria, Fakhrzadeh, Hossein, Payab, Moloud, Ebrahimpur, Mahbube, Khorashadi, Masoumeh, Khodabakhshi, Huriye, Esmaeili, Ali Akbar, Sharifzadeh, Gholamreza, Zarban, Asghar, Sharifi, Farshad, Sajjadi-Jazi, Sayed Mahmoud. Prevalence of thyroid dysfunction among Iranian older adults: a cross-sectional study. Scientific reports, vol.13, no.1, 21651-.

  40. Zhou, Jianxing, Wei, Zipeng, Zheng, You, Xie, Helin, Cao, Wanxia, Cai, Xinying, Huang, Jialin, Wu, Xuemei. Disproportionality Analysis of Lenvatinib‐Caused Gastrointestinal Perforation in Cancer Patients: A Pharmacovigilance Analysis Based on the US Food and Drug Administration Adverse Event Reporting System. The Journal of clinical pharmacology, vol.63, no.10, 1133-1140.

  41. Jurado-Flores, Marilu, Warda, Firas, Mooradian, Arshag. Pathophysiology and Clinical Features of Neuropsychiatric Manifestations of Thyroid Disease. Journal of the endocrine society, vol.6, no.2, bvab194-.

  42. Tobore, Tobore Onojighofia. On the central role of mitochondria dysfunction and oxidative stress in Alzheimer’s disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, vol.40, no.8, 1527-1540.

  43. Bavarsad, Kowsar, Hosseini, Mahmoud, Hadjzadeh, Mousa‐Al‐Reza, Sahebkar, Amirhossein. The effects of thyroid hormones on memory impairment and Alzheimer's disease. Journal of cellular physiology, vol.234, no.9, 14633-14640.

  44. Quinlan, Patrick, Horvath, Alexandra, Eckerström, Carl, Wallin, Anders, Svensson, Johan. Altered thyroid hormone profile in patients with Alzheimer’s disease. Psychoneuroendocrinology, vol.121, 104844-.

  45. Sakaeda, Toshiyuki, Tamon, Akiko, Kadoyama, Kaori, Okuno, Yasushi. Data Mining of the Public Version of the FDA Adverse Event Reporting System. International journal of medical sciences, vol.10, no.7, 796-803.

  46. Khaleel, Mohammad Ali, Khan, Amer Hayat, Ghadzi, Siti Maisharah Sheikh, Adnan, Azreen Syazril, Abdallah, Qasem M.. A Standardized Dataset of a Spontaneous Adverse Event Reporting System. Healthcare, vol.10, no.3, 420-.

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로